The store will not work correctly when cookies are disabled.
3-((4-Hydroxyphenylamino)-4-(2-(trifluoromethyl)phenyl)-1H-pyrrole-2,5-dione
ID: ALA4876241
PubChem CID: 164626363
Max Phase: Preclinical
Molecular Formula: C17H11F3N2O3
Molecular Weight: 348.28
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1NC(=O)C(c2ccccc2C(F)(F)F)=C1Nc1ccc(O)cc1
Standard InChI: InChI=1S/C17H11F3N2O3/c18-17(19,20)12-4-2-1-3-11(12)13-14(16(25)22-15(13)24)21-9-5-7-10(23)8-6-9/h1-8,23H,(H2,21,22,24,25)
Standard InChI Key: IFMZEAZJVSSENT-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
1.6385 -1.5931 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.6426 -2.4103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3483 -1.9981 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.2801 -2.4506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0973 -2.4506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3517 -1.6739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6887 -1.1918 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.0300 -1.6739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8556 -3.1489 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0363 -3.1291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6113 -3.8276 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0044 -4.5464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8269 -4.5624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2483 -3.8632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5769 -3.1123 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3902 -3.1119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7953 -3.8184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6078 -3.8183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0150 -3.1133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6036 -2.4068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7924 -2.4103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1292 -1.4225 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.2526 -1.4217 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.8276 -2.3926 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
7.8322 -3.1118 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 2 0
5 6 1 0
6 7 1 0
7 8 1 0
8 4 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
9 4 1 0
5 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
6 22 2 0
8 23 2 0
10 2 1 0
2 24 1 0
19 25 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 348.28 | Molecular Weight (Monoisotopic): 348.0722 | AlogP: 2.89 | #Rotatable Bonds: 3 |
Polar Surface Area: 78.43 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.64 | CX Basic pKa: ┄ | CX LogP: 2.52 | CX LogD: 2.52 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.59 | Np Likeness Score: -0.28 |
References
1. Serafim RAM, Sorrell FJ, Berger BT, Collins RJ, Vasconcelos SNS, Massirer KB, Knapp S, Bennett J, Fedorov O, Patel H, Zuercher WJ, Elkins JM.. (2021) Discovery of a Potent Dual SLK/STK10 Inhibitor Based on a Maleimide Scaffold., 64 (18.0): [PMID:34463505] [10.1021/acs.jmedchem.0c01579] |